Generated by AI
InspireMD, Inc. is a medical device company that develops and commercializes products for the treatment of carotid artery disease and other vascular conditions. The company’s portfolio centers on its proprietary CGuard™ carotid stent platform and MicroNet™ mesh technology, which are designed to support embolic protection during and after stenting procedures. InspireMD’s current products include carotid embolic prevention and stent systems used in vascular and neurovascular interventions, with applications across stroke prevention and related artery treatment settings. The company serves physicians, hospitals, and healthcare providers in multiple international markets, including the United States and select regions in Europe, the Middle East, Latin America, and Asia Pacific. InspireMD plays a specialized role in the medical technology market by focusing on device-based solutions for complex carotid and coronary care.
Website6303 Waterford District Drive
Miami, FL, 33126
United States
The latest articles about NSPR.
InspireMD Inc (NSPR) eyes a warm US launch for its next-generation carotid implant while cost cuts and a proposed equity offering shore up liquidity amid a narrower quarterly loss.
Summary of Nov 13's posts. Generated by AI.
Summary of Oct 21's posts. Generated by AI.
Summary of May 15's posts. Generated by AI.
Summary of Oct 21's posts. Generated by AI.
Investors talking about NSPR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.